TRCT
IBDQ

Tower Research Capital (TRC)’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Tower Research Capital (TRC)’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,926
Closed -$48.5K – 5345
2025
Q3 		$48.5K Sell
1,926
-1,644
-46% -$41.3K ﹤0.01% 2542
2025
Q2 		$89.9K Buy
3,570
+2,387
+202% +$60K ﹤0.01% 2470
2025
Q1 		$29.8K Buy
+1,183
New +$29.7K ﹤0.01% 2621
2024
Q3 		– Sell
-100
Closed -$2.49K – 5833
2024
Q2 		$2.49K Hold
100
– – ﹤0.01% 4999
2024
Q1 		$2.48K Hold
100
– – ﹤0.01% 5030
2023
Q4 		$2.48K Hold
100
– – ﹤0.01% 5211
2023
Q3 		$2.44K Hold
100
– – ﹤0.01% 5153
2023
Q2 		$2.44K Buy
+100
New +$2.45K ﹤0.01% 5199
2017
Q2 		– Sell
-878
Closed -$22K – 3031
2017
Q1 		$22K Buy
+878
New +$21.5K ﹤0.01% 1243

Other funds holding IBDQ

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Tower Research Capital (TRC)'s IBDQ Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 1,926 shares — an estimated $48.5K sold.

Tower Research Capital (TRC) first reported a position in IBDQ in Q1 2017 and held it in 9 quarters. The position peaked at $89.9K in Q2 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,926 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $48.5K.
  • Tower Research Capital (TRC) first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q1 2017 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s iShares iBonds Dec 2025 Term Corporate ETF position peaked at $89.9K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.